Alterna Wealth Management’s Host Hotels & Resorts HST Stock Holding History

Alterna Wealth Management’s Portfolio HST Stock Details HST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,101	Closed	-$194K	–	117
2022 Q4	$194K	Hold	12,101	–	–	0.22%	92
2022 Q3	$192K	Buy	+12,101	New	+$211K	0.23%	78

Other funds holding HST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alterna Wealth Management's HST Position: Q1 2023 in Review

Alterna Wealth Management sold out of Host Hotels & Resorts (HST) in Q1 2023, closing a stake of 12,101 shares — an estimated $194K sold.

Alterna Wealth Management first reported a position in HST in Q3 2022 and held it in 2 quarters. The position peaked at $194K in Q4 2022. 535 funds tracked by Wall St. Rank hold HST as of Q1 2023.

Alterna Wealth Management reported no remaining Host Hotels & Resorts position as of Q1 2023 after selling out during the quarter.
Alterna Wealth Management sold 12,101 Host Hotels & Resorts shares in Q1 2023, an estimated $194K.
Alterna Wealth Management first reported a position in Host Hotels & Resorts in Q3 2022 and held it in 2 quarters.
Alterna Wealth Management's Host Hotels & Resorts position peaked at $194K in Q4 2022.
535 funds tracked by Wall St. Rank held Host Hotels & Resorts as of Q1 2023.

Based on Alterna Wealth Management's 13F filing for Q1 2023, filed 26 May 2023.